Delivery Order SPE2DB22D3301-SPE2DB24FX4TW
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.40 firm-fixed price delivery order is for the supply of Fluorescein Sodium 10% Vial, 5 mL, a pharmaceutical product used in various medical applications. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FEF98, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,313.06, is for the delivery of 4566437225 - FLUORESCITE 10% VIAL 5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 15, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award, valued at $1,607.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of a medical product, "FLUORESCITE 10% VIAL 5ML", with a completion date of March 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- The Defense Logistics Agency awarded a $7,473.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fluorescein Sodium 10% Vial 5ml, with an ultimate completion date of November 12, 2025. This non-set-aside contract was competitively awarded on November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies medical...
- The federal contract award, identified as SPE2DB20D3103|SPE2DB24FQ3V6, was made to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,193.62 firm-fixed-price delivery order is for the supply of 4565879140 - AK-FLUOR 10% VIAL 5ML, with a completion date of September 20, 2024. This award is not associated with any set-aside program. Amerisourcebergen holds several Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,800 for the supply of Fluorescein 1mg (300 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is due for completion by October 9, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a defense agency component responsible for pharmaceutical procurement to support military and veteran healthcare systems. This delivery order represents a...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.04 firm fixed-price contract is for the procurement of AK-FLUOR 10% vials (5 mL). This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, with ID SPE2DX16D4015|SPE2DX24FL812, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $43,814.48 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., both of which are for-profit organizations registered in the System for Award Management (SAM.gov). The contract provides for the delivery...
- This federal contract award, with the ID SPE2DX15D5017|SPE2DX23FC038, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $45,136.60 and is a Firm Fixed Price Delivery Order with a period of performance through May 2, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, with ID SPE2DX15D6028|SPE2DX23FWTAL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $19,681.34 firm fixed-price delivery order is for the supply of 4,561,514,905 units of the medication Fluorometholone 5ML 1S. The contract has an ultimate completion date of August 11, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX4TWDelivery Order
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB24FX4TW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorescein Sodium 10% Vial 5ml, a medical product, with a total ceiling value of $44,022.85. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is November 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.0k | 11/1/23 |